ADHD can shorten life expectancy by nearly a decade. Yet, many adults go undiagnosed. Here’s what women need to know.

Before lithium became available to treat this potentially devastating illness, bipolar I sufferers experienced repeated ...

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...

Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...

Biohaven's NDA for Troriluzole was accepted by the FDA, potentially leading to approval in Q3 2025. Click here to find out ...

The Sandbox Collective’s “Next to Normal” is a cathartic presentation of what it’s like to be human: to feel, to grieve, to ...

Biohaven boasts a robust pipeline with late-stage molecules, but a Hold rating reflects its high market cap and uncertain ...

Many people get the “winter blues,” a mild sadness as the days get colder and shorter. But some people experience clinical ...

Q4 2024 Management View CEO Mihael Polymeropoulos highlighted strong revenue growth for Fanapt, driven by its launch for bipolar I disorder and increased new-to-brand prescriptions by over 160% ...